Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 20 Aug 2026 for Acrivon Therapeutics, Inc., €694. Read the official filing
Filing timeline
BuySaleErick Gamelin
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Erick Gamelin: trading record in brief
Erick Gamelin is a declared insider of Acrivon Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 12 filings cover trades dated from 14 November 2022 to 18 August 2026.
On the market, this insider has only sold: 1 sale, €694 in total. The rest of the record consists of 11 share grants. In 2026 alone, the filings show no purchases and 1 sale.
The newest entry dates from 20 August 2026: an open-market sale of €694, in Acrivon Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Erick Gamelin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
400 shares@ US$2.01Common StockSEC:0000905148-26-003838:0
471 shares@ US$1.633.0% of flowCommon StockSEC:0000905148-26-000936:0
403 shares@ US$2.243.8% of flowCommon StockSEC:0000905148-25-004129:0
403 shares@ US$1.392.3% of flowCommon StockSEC:0000905148-25-003041:0
403 shares@ US$1.142.0% of flowCommon StockSEC:0000905148-25-001822:0
469 shares@ US$5.4211.9% of flowCommon StockSEC:0000905148-25-000727:0
402 shares@ US$7.9214.8% of flowCommon StockSEC:0000905148-24-003225:0
402 shares@ US$7.0212.6% of flowCommon StockSEC:0000905148-24-002279:0
402 shares@ US$8.3615.2% of flowCommon StockSEC:0000905148-24-001487:0
468 shares@ US$3.407.3% of flowCommon StockSEC:0000905148-24-000762:0
1,395 shares@ US$5.0832.4% of flowCommon StockSEC:0000905148-23-001474:0
20,030 shares0Common StockSEC:0001209191-22-057400:0
12 of 12 declarations
